Table 1. Demographic information and clinical features of patients with HCCs expressing low versus high levels of PCAF compared with the adjacent benign tissue.

	Low PCAF group (number; %)	High PCAF group	χ2	P
Gender
Male	60 (69.8%)	20	0.500	0.479
Female	26 (30.2%)	6
Age (years)
⩾50	46 (54.8%)	17	2.735	0.098
<50	38 (45.2%)	6
APF (ng/dl)
⩾400	36 (50%)	14	0.347	0.556
<400	36 (50%)	18
HBsAg
Positive	40 (81.6%)	8	0.015	0.904
Negative	9 (18.4%)	2
Etiology
HBV or HCV infection	53 (67.1%)	20	0.213	0.644
Other	26 (32.9%)	12
Tumor size (cm)
⩾5	48 (68.6%)	19	1.193	0.274
<5	22 (31.4%)	14
Liver cirrhosis
Yes	37 (43%)	11	0.004	0.949
No	49 (57%)	15
TNM staging
I+II	14 (30.4%)	3	3.289	0.070
III+IV	32 (69.6%)	23